K M Curtis

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. doi request reprint Adaptation of the World Health Organization's Selected Practice Recommendations for Contraceptive Use for the United States
    Kathryn M Curtis
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 87:513-6. 2013
  2. ncbi request reprint Use of combined oral contraceptives among women with migraine and nonmigrainous headaches: a systematic review
    Kathryn M Curtis
    WHO Collaborating Center in Reproductive Health, Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 73:189-94. 2006
  3. ncbi request reprint Regret following female sterilization at a young age: a systematic review
    Kathryn M Curtis
    WHO Collaborating Center in Reproductive Health, Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 73:205-10. 2006
  4. ncbi request reprint Progestogen-only contraception and bone mineral density: a systematic review
    Kathryn M Curtis
    Division of Reproductive Health, WHO Collaborating Center in Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 73:470-87. 2006
  5. ncbi request reprint Neoplasia with use of intrauterine devices
    Kathryn M Curtis
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 75:S60-9. 2007
  6. doi request reprint Progestogen-only contraceptive use in obese women
    Kathryn M Curtis
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 80:346-54. 2009
  7. doi request reprint Safety of hormonal and intrauterine methods of contraception for women with HIV/AIDS: a systematic review
    Kathryn M Curtis
    Division of Reproductive Health, Centers for Disease Control and Prevention, MS K 34, 4770 Buford Highway NE, Atlanta, GA 30341, USA
    AIDS 23:S55-67. 2009
  8. doi request reprint Adaptation of the World Health Organization's medical eligibility criteria for contraceptive use for use in the United States
    Kathryn M Curtis
    Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 82:3-9. 2010
  9. doi request reprint Putting risk into perspective: the US medical eligibility criteria for contraceptive use
    Kathryn M Curtis
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Rev Endocr Metab Disord 12:119-25. 2011
  10. doi request reprint U.S. medical eligibility criteria for contraceptive use, 2010
    Kathryn M Curtis
    Division of Reproductive Health, Centers for Disease Control and Prevention, 4770 Buford Highway NE, Atlanta, GA 30341, USA
    J Womens Health (Larchmt) 20:825-8. 2011

Collaborators

Detail Information

Publications32

  1. doi request reprint Adaptation of the World Health Organization's Selected Practice Recommendations for Contraceptive Use for the United States
    Kathryn M Curtis
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 87:513-6. 2013
    ..The WHO guidance includes evidence-based recommendations on common, yet sometimes complex, contraceptive management questions...
  2. ncbi request reprint Use of combined oral contraceptives among women with migraine and nonmigrainous headaches: a systematic review
    Kathryn M Curtis
    WHO Collaborating Center in Reproductive Health, Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 73:189-94. 2006
    ..The three studies that provided evidence on hemorrhagic stroke reported low or no risk associated with migraine or with COC use...
  3. ncbi request reprint Regret following female sterilization at a young age: a systematic review
    Kathryn M Curtis
    WHO Collaborating Center in Reproductive Health, Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 73:205-10. 2006
    ..Results of studies that examined risk by continuous age showed a consistent inverse relationship between women's age at sterilization and their likelihood of regretting having had the procedure...
  4. ncbi request reprint Progestogen-only contraception and bone mineral density: a systematic review
    Kathryn M Curtis
    Division of Reproductive Health, WHO Collaborating Center in Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 73:470-87. 2006
    ..Limited evidence suggested that use of progestogen-only contraceptives other than DMPA did not affect BMD...
  5. ncbi request reprint Neoplasia with use of intrauterine devices
    Kathryn M Curtis
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 75:S60-9. 2007
    ..Additionally, hormone-releasing IUDs or intrauterine systems (IUSs) release progestins or progesterone into the uterus. Both of these mechanisms may affect users' risk for neoplasia...
  6. doi request reprint Progestogen-only contraceptive use in obese women
    Kathryn M Curtis
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 80:346-54. 2009
    ..The objective of this systematic review is to determine whether obese women who use progestogen-only contraceptives are more likely to experience weight gain or serious adverse events as compared to nonobese users...
  7. doi request reprint Safety of hormonal and intrauterine methods of contraception for women with HIV/AIDS: a systematic review
    Kathryn M Curtis
    Division of Reproductive Health, Centers for Disease Control and Prevention, MS K 34, 4770 Buford Highway NE, Atlanta, GA 30341, USA
    AIDS 23:S55-67. 2009
    ..To determine from the literature whether HIV-infected women who use hormonal or intrauterine contraception are at increased risk of HIV disease progression, other adverse health outcomes, or HIV transmission to uninfected sexual partners...
  8. doi request reprint Adaptation of the World Health Organization's medical eligibility criteria for contraceptive use for use in the United States
    Kathryn M Curtis
    Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 82:3-9. 2010
    ..This guidance includes recommendations for use of specific contraceptive methods by people with certain characteristics or medical conditions...
  9. doi request reprint Putting risk into perspective: the US medical eligibility criteria for contraceptive use
    Kathryn M Curtis
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Rev Endocr Metab Disord 12:119-25. 2011
    ..Most women, even women with medical conditions, can safely use highly effective methods of contraception and promoting their use will further efforts to reduce unintended pregnancy...
  10. doi request reprint U.S. medical eligibility criteria for contraceptive use, 2010
    Kathryn M Curtis
    Division of Reproductive Health, Centers for Disease Control and Prevention, 4770 Buford Highway NE, Atlanta, GA 30341, USA
    J Womens Health (Larchmt) 20:825-8. 2011
    ..Most women, even those with medical conditions, can safely use most methods of contraception...
  11. ncbi request reprint Combined oral contraceptive use among women with hypertension: a systematic review
    Kathryn M Curtis
    WHO Collaborating Center in Reproductive Health, Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 73:179-88. 2006
    ..Women who did not have their blood pressure measured before initiating COC use were at higher risk for ischemic stroke and AMI, but not for hemorrhagic stroke or VTE, than COC users who did not have their blood pressure measured...
  12. ncbi request reprint Visits to emergency departments for gynecologic disorders in the United States, 1992-1994
    K M Curtis
    Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30341 3717, USA
    Obstet Gynecol 91:1007-12. 1998
    ..To assess rates of visits to emergency departments for gynecologic disorders among women of reproductive age in the United States...
  13. ncbi request reprint Effective use of hormonal contraceptives: Part I: Combined oral contraceptive pills
    Kathryn M Curtis
    World Health Organization Collaborating Center in Reproductive Health, Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 73:115-24. 2006
    ....
  14. ncbi request reprint Contraception for women in selected circumstances
    Kathryn M Curtis
    World Health Organization Collaborating Center in Reproductive Health, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA
    Obstet Gynecol 99:1100-12. 2002
    ..To review new evidence regarding ten controversial issues in the use of contraceptive methods among women with special conditions and to present World Health Organization recommendations derived in part from this evidence...
  15. ncbi request reprint Safety of implantable contraceptives for women: data from observational studies
    Kathryn M Curtis
    Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Contraception 65:85-96. 2002
    ..Nonsignificantly elevated associations were reported for diabetes, serious mental disorders, and rheumatoid arthritis. Conditions for which risks were marginally, yet significantly, elevated were hypertension and gall bladder disease...
  16. ncbi request reprint Maternal obesity and risk of cesarean delivery: a meta-analysis
    S Y Chu
    Division of Reproductive Health, Centers for Disease Control and Prevention, Mailstop K23, 1600 Clifton Road, Atlanta, GA 30333, USA
    Obes Rev 8:385-94. 2007
    ..The meta-regression found no evidence that these estimates were affected by selected study characteristics. Our findings provide a quantitative estimate of the risk of cesarean delivery associated with high maternal body mass...
  17. ncbi request reprint Pregnancy intention and its relationship to birth and maternal outcomes
    A P Mohllajee
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Obstet Gynecol 109:678-86. 2007
    ....
  18. ncbi request reprint Effects of injectable or implantable progestin-only contraceptives on insulin-glucose metabolism and diabetes risk
    Henry S Kahn
    Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA
    Diabetes Care 26:216-25. 2003
    ..Additional research could help clarify whether exposure to injectable or implantable contraceptives leads to increased risk of type 2 diabetes and gestational diabetes in women with predisposing factors...
  19. ncbi request reprint Reproductive history and mortality after breast cancer diagnosis
    Maura K Whiteman
    Division of Applied Public Health Training, Epidemiology Program Office, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA
    Obstet Gynecol 104:146-54. 2004
    ..To assess whether reproductive factors are associated with mortality after breast cancer diagnosis...
  20. ncbi request reprint Maternal obesity and risk of stillbirth: a metaanalysis
    Susan Y Chu
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Am J Obstet Gynecol 197:223-8. 2007
    ..Maternal obesity is associated with an increased risk of stillbirth, although the mechanisms to explain this association are not clear...
  21. ncbi request reprint Body mass and mortality after breast cancer diagnosis
    Maura K Whiteman
    Epidemic Intelligence Service, Division of Applied Public Health Training, Epidemiology Program Office, Centers for Disease Control and Prevention, 4770 Buford Highway Northeast, Mailstop K 34, Atlanta, GA 30341 3724, USA
    Cancer Epidemiol Biomarkers Prev 14:2009-14. 2005
    ..Obesity could be a preventable risk factor for death among breast cancer patients. Further study is needed to determine how these findings might affect recommendations to reduce breast cancer mortality...
  22. ncbi request reprint Clinical practice. Long-acting methods of contraception
    Herbert B Peterson
    Department of Maternal and Child Health, School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, USA
    N Engl J Med 353:2169-75. 2005
  23. ncbi request reprint Combined hormonal contraception and bone health: a systematic review
    Summer L Martins
    Division of Reproductive Health, WHO Collaborating Center in Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 73:445-69. 2006
    ....
  24. ncbi request reprint Effective use of hormonal contraceptives: Part II: Combined hormonal injectables, progestogen-only injectables and contraceptive implants
    Camaryn E Chrisman
    Wake Forest University School of Medicine, Winston Salem, NC 27157, USA
    Contraception 73:125-33. 2006
    ..Norplant implants left in place for up to seven completed years remained effective among women who weighed <70 kg at the time of implant insertion, but their effectiveness decreased among women weighing >or=70 kg...
  25. ncbi request reprint Progestogen-only contraceptive use among women with sickle cell anemia: a systematic review
    Jennifer K Legardy
    WHO Collaborating Center in Reproductive Health, Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 73:195-204. 2006
    ..Although data are limited, these studies suggest that progestogen-only contraceptives are safe for women with sickle cell anemia...
  26. ncbi request reprint Acceptance and use of emergency contraception with standardized counseling intervention: results of a randomized controlled trial
    Ruth Petersen
    Department of Maternal and Child Health, School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
    Contraception 75:119-25. 2007
    ..The objective of this work was to evaluate the acceptance, use and recall of an optional advance prescription for emergency contraception (EC)...
  27. ncbi request reprint Hormonal contraceptive use and risk of sexually transmitted infections: a systematic review
    Anshu P Mohllajee
    Centers for Disease Control and Prevention, Division of Reproductive Health, WHO Collaborating Center in Reproductive Health, Atlanta, GA 30341, USA
    Contraception 73:154-65. 2006
    ..The observed positive associations may be due to a true association or to bias, such as differential exposure to STIs by contraceptive use or increased likelihood of STI detection among hormonal contraceptive users...
  28. ncbi request reprint Medical eligibility criteria for new contraceptive methods: combined hormonal patch, combined hormonal vaginal ring and the etonogestrel implant
    Mary E Gaffield
    Department of Reproductive Health and Research, World Health Organization, CH 1211 Geneva 27, Switzerland
    Contraception 73:134-44. 2006
    ..Limited evidence also suggests no adverse effects of the etonogestrel implant on lactation parameters or infant development among users enrolled 28 to 56 days postpartum and followed for 4 months...
  29. ncbi request reprint Keeping up with evidence a new system for WHO's evidence-based family planning guidance
    Anshu P Mohllajee
    WHO Collaborating Center in Reproductive Health, Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA
    Am J Prev Med 28:483-90. 2005
    ....
  30. ncbi request reprint Study design to evaluate the safety and effectiveness of hormonal contraception for women
    Nathalie Kapp
    Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland
    Clin Obstet Gynecol 50:850-67. 2007
    ..Observational studies, experimental studies, and meta-analysis in hormonal contraception are also reviewed...
  31. ncbi request reprint Use of evidence in WHO recommendations
    Herbert B Peterson
    Lancet 370:825; author reply 826-7. 2007
  32. ncbi request reprint Does insertion and use of an intrauterine device increase the risk of pelvic inflammatory disease among women with sexually transmitted infection? A systematic review
    Anshu P Mohllajee
    Division of Reproductive Health, WHO Collaborating Center in Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 73:145-53. 2006
    ..The absolute risk of PID was low for both groups (0-5% for those with STIs and 0-2% for those without)...